SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-046765
Filing Date
2022-02-18
Accepted
2022-02-18 17:29:29
Documents
12
Period of Report
2022-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d290085d8k.htm   iXBRL 8-K 23834
  Complete submission text file 0001193125-22-046765.txt   148451

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adgi-20220214.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adgi-20220214_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adgi-20220214_pre.xml EX-101.PRE 11702
6 EXTRACTED XBRL INSTANCE DOCUMENT d290085d8k_htm.xml XML 3459
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 22654027
SIC: 2836 Biological Products, (No Diagnostic Substances)